Page last updated: 2024-11-05

trazodone and Cardiac Diseases

trazodone has been researched along with Cardiac Diseases in 2 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Himmelhoch, JM1
Schechtman, K1
Auchenbach, R1
Bucknall, C1
Brooks, D1
Curry, PV1
Bridges, PK1
Bouras, N1
Ankier, SI1

Trials

1 trial available for trazodone and Cardiac Diseases

ArticleYear
Mianserin and trazodone for cardiac patients with depression.
    European journal of clinical pharmacology, 1988, Volume: 33, Issue:6

    Topics: Adult; Aged; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Heart Diseases; Hemo

1988

Other Studies

1 other study available for trazodone and Cardiac Diseases

ArticleYear
The role of trazodone in the treatment of depressed cardiac patients.
    Psychopathology, 1984, Volume: 17 Suppl 2

    Topics: Aged; Anxiety Disorders; Arrhythmias, Cardiac; Bipolar Disorder; Cardiac Complexes, Premature; Depre

1984